21.47USDMkt Cap: 86.86M USDP/E: —Last update: 2026-05-22
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap86.86M USD
Enterprise Value67.32M USD
Revenue (TTM)32.73M USD
Gross Profit-2.11M USD
Net Income (TTM)-26.60M USD
Revenue/Share8.750 USD
Last Price21.47 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS22978P1066
Valuation
P/E (Trailing)—
P/E (Forward)-41.88
PEG—
EV/EBITDA-3.71
EV/Revenue2.06
P/S2.48
P/B3.03
EPS (TTM)-4.53
EPS (Forward)-0.48
52W Range
19.4069% of range22.41
52W High22.41 USD
52W Low19.40 USD
Profitability
Gross Margin-6.45%
Oper. Margin-94.32%
EBITDA Margin-55.49%
Profit Margin-96.85%
ROE-100.64%
ROA-63.02%
Growth
Revenue Growth1250.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.69M USD
CapEx (TTM)177.00K USD
FCF Margin-41.57%
FCF Yield-15.66%
Net Debt-14.00M USD
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity0.16
Current Ratio3.57
Quick Ratio3.34
Book Value/Sh6.638 USD
Cash/Share4.311 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateApr 24, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)115.00 USD
Target Range115.00 USD – 115.00 USD
# Analysts1
Ownership
Shares Out.4.05M
Float3.61M
Insiders13.63%
Institutions528.77%
Short Interest
Short Ratio0.3d
Short % Float8.91%
Short % Out.8.87%
Shares Short288.89K
Short (prev mo.)88.82K
Technical
SMA 5016.54 (+29.8%)
SMA 20016.83 (+27.6%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)61.15K
Avg Vol (10d)172.20K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—